Statement of Organization, Functions, and Delegations of Authority, 509-511 [2011-33791]
Download as PDF
<![CDATA[
509
Federal Register / Vol. 77, No. 3 / Thursday, January 5, 2012 / Notices
complete pre-/post-campaign
questionnaires for non-smokers is 2,000.
To obtain the target number of
complete pre-/post-campaign responses,
approximately 34,660 respondents will
be contacted through an initial
screening and consent process. The
estimated burden per response is two
minutes.
An estimated 11,600 smokers will be
recruited to complete the Smoker
Baseline Questionnaire in order to yield
5,000 completed post-campaign Smoker
Follow-Up Questionnaires. An
estimated 2,666 non-smokers will be
recruited to complete the Non-smoker
Baseline Questionnaire in order to yield
2,000 completed post-campaign Nonsmoker Follow-up Questionnaires. For
both respondent groups, the estimated
burden per response is 25 minutes for
each baseline questionnaire. In addition,
the estimated burden per response is 25
minutes for each post-campaign (followup) questionnaire.
Data from this information collection
will be used to estimate awareness of
and exposure to The Campaign among
smokers and non-smokers nationally as
well as among the planned subset of
smokers in high-delivery geographic
areas for The Campaign. These estimates
will take the form of self-reported ad
recognition and recall estimates that
assess basic exposure as well as
frequency of ad exposure. Data from this
information collection will also be used
to examine statistical associations
between exposure to The Campaign and
pre-post changes in specific outcomes of
interest which will include knowledge,
attitudes, beliefs and intentions related
to smoking and cessation as well as
behavioral outcomes including quit
attempts and cigarette consumption.
OMB approval is requested for one
year. There are no costs to respondents
other than their time. The total
estimated burden hours are 10,015.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
General Population .........................................
Adults, ages 18–54 in the U.S. .......................
Screening and Consent Process ...................
Smoker Baseline Questionnaire ....................
Smoker Follow-Up Questionnaire ..................
Non-Smoker Baseline Questionnaire .............
Non-Smoker Follow-up Questionnaire ...........
Dated: December 29, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–33799 Filed 1–4–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK5VPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 PR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 66308–66309,
dated October 26, 2011) is amended to
reflect the reorganization of the
Financial Management Office within the
Office of the Chief Operating Officer,
Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete items (1), (2) and (3) of the
functional statements for the Financial
Management Office (CAJE), and insert
the following: (1) Provides leadership
VerDate Mar<15>2010
14:51 Jan 04, 2012
Jkt 226001
and coordination in the development
and administration of the Centers for
Disease Control and Prevention’s (CDC)
financial management policies; (2)
provides leadership and advice on
matters of public health policy, budget
formulation, budget and performance
integration, and Congressional
appropriations for CDC and the Agency
for Toxic Substances and Disease
Registry (ATSDR); (3) collaborates with
the CDC Office of the Director (OD) in
the development and implementation of
long-range, strategic program and
financial plans;
Delete in its entirety the title and
functional statements for the Travel
Management Activity (CAJE12).
Delete in its entirety the title and
functional statements for the Office of
Organizational Excellence (CAJE13) and
the Office of Formulation, Evaluation,
and Analysis (CAJE14) and insert the
following:
Office of Management Services
(CAJE13). (1) Collaborates and
maintains liaison with CDC
management officials to monitor and
address priority issues of concern to
CDC leadership; (2) manages the
Financial Management Office’s (FMO)
operational budget processes, including
planning, execution, and monitoring; (3)
manages FMO’s acquisition processes;
(4) analyzes and provides
recommendations on workload
efficiency and resource utilization; (5)
provides direction, strategy, analysis,
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
34,660
11,600
5,000
2,666
2,000
Number of
responses per
respondent
1
1
1
1
1
Average
burden per
response
(in hours)
2/60
25/60
25/60
25/60
25/60
operational support, and
recommendations in matters concerning
organizational performance and
management services within FMO; (6)
coordinates the development of, and
maintains, strategic management and
performance measurement tools within
FMO; (7) monitors FMO organizational
performance and provides
recommendations on performance
improvement; (8) provides management,
oversight, and administrative support
for FMO service desk operations; (9)
provides direction, strategy, analysis,
and operational support in all aspects of
FMO’s human resources operations; (10)
provides leading practices in
government financial management
practices to FMO; (11) develops,
implements, and manages recruiting,
hiring, retention, and succession
strategies; (12) coordinates creation and
implementation of operating standards/
procedures and processes, and monitors
compliance; (13) develops, implements,
and manages professional development
strategy and plan for FMO; (14)
develops and implements FMO’s
communication strategy and plan; (15)
manages the development and
communication of financial
management policies; (16) serves as
FMO’s point of contact on all matters
concerning facilities management and
space utilization; and (17) serves as
FMO’s coordinator of COOP activities.
Appropriations, Legislation, and
Formulation Office (CAJE14). (1)
E:\FR\FM\05JAN1.SGM
05JAN1
emcdonald on DSK5VPTVN1PROD with NOTICES
510
Federal Register / Vol. 77, No. 3 / Thursday, January 5, 2012 / Notices
Provides leadership, consultation,
guidance, and advice on matters of
public health and financial policy; (2)
leads all CDC/ATSDR Congressional
appropriations activities; (3) develops
CDC/ATSDR’s annual financial and
public health policy request in
accordance with DHHS, Office of
Management and Budget (OMB), and
Congressional requirements, policies,
procedures, and regulations; (4)
maintains liaison with the DHHS, OMB,
other government organizations, and
Congress on appropriations and
financial policy matters; (5) develops
materials for, and participates in, public
health policy and financial reviews and
hearings before DHHS, OMB, and
Congress; (6) collaborates with other
parts of CDC, and outside stakeholders,
in the development and implementation
of agency-wide financial and public
health program plans; and (7) provides
guidance and advice on the
consolidation of budget and
performance information as part of
CDC’s annual budget request.
Delete the functional statements for
the Accounting Branch (CAJEB) and the
Commercial Payment Branch (CAJEE)
and insert the following:
Accounting Branch (CAJEB). (1)
Oversees and provides accounting for
the Agency; (2) manages accounting
treatment for CDC on all business
systems implementations and upgrades
to current business systems; (3) manages
all financial audit reviews for FMO and
conducts risk assessment on internal
controls; (4) prepares SF 133 Report on
Budget Execution for CDC
Appropriation and IDDAs, FACTS I and
IT Report and Year-End Closing
Statement (2108 Report), and SF 224 or
their equivalent and all other required
financial reports as applicable; (5)
prepares, analyzes fluctuations, and
coordinates explanation for differences
on all required financial statements and
notes: (6) performs GPRA reporting
analysis for compliance; (7) ensures
compliance of Federal and Department
reporting requirements; (8) coordinates
accounting policy issues with the
Department of Health and Human
Services (DHHS) Office of Financial
Policy and FMO’s Office of Management
Services; (9) manages Fund Balance
with Treasury, including authority,
disbursements (payroll and nonpayroll), collections, deposit funds and
budget clearing accounts; (10) prepares
manual and ADI journal vouchers for
corrections to the general ledger; (11)
performs monthly, quarterly, and yearend close out process of the general
ledger; (12) serves as liaison with the
Procurements and Grants Office,
Buildings and Facilities Offices,
VerDate Mar<15>2010
14:51 Jan 04, 2012
Jkt 226001
Program Offices, and Budget Execution
Services on capital asset procedures;
(13) manages financial accounting for all
assets for CDC, including real and
personal property, equipment, land,
leases, software, personal property, and
stockpiles; (14) conducts financial and
inventory reconciliations for all
applicable assets, including inventory
such as Vaccine for Children and
Strategic National Stockpile, real and
personal property, equipment, leases,
leasehold improvements, land, and
others as needed; (15) leads and directs
grants management activities within
FMO; (16) provides training and
assistance to CDC project officers and
grants management officials on various
financial management aspects of grants;
(17) serves as liaison with grantees and
other operating divisions for financial
questions/inquiries related to grants;
(18) manages the process to perform
grant processing for commitments,
obligations, advances, disbursements,
and accruals; (19) manages grants
transactions, such as vendor set-up,
establishing sub-accounts, Common
Accounting Number set-up within the
Payment Management System (PMS),
reconciling sync file to PMS, and
posting files from PMS; (20) conducts
grant reviews, monitors rates of
expenditure for existing grant awards,
and supports Program in grant
execution; and (21) records undelivered
order adjustments or obligations as
needed.
Commercial Payment Branch (CAJEE).
(1) Manages all activities, policies,
quality control, and audit support for
accounts payable and disbursement
functions for commercial payments; (2)
serves as the CDC subject matter expert
on all financial matters dealing with
commercial payments; (3) ensures all
commercial payments are made in
accordance with applicable Federal
laws and standards, such as
Appropriations Law; (4) serves as
liaison with the Department of Treasury,
the Centers/Institutes/Offices (CIO’s), as
well as outside customers, to provide
financial information and reconcile
commercial payment issues; (5)
provides training and advice on
commercial payment and disbursement
issues; (6) manages transactions related
to commercial accounts payable and
disbursements; (7) completes all
reconciliations of sub-legers to general
ledger related to commercial payments;
(8) compiles and submits a variety of
cash management and commercial
reports required by Treasury and
various outside agencies; (9) responds to
commercial inquiries for invoices and
certifies payments; (10) performs
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Quality Control and Quality Assurance
reviews and participates in internal
reviews; and (11) assists with
undelivered order adjustments or
obligations as needed.
Delete in its entirety the title and
function statements for the Grants and
Asset Management Branch (CAJEK).
After the functional statements for the
Budget Execution Branch 6 (CAJES)
insert the following:
Travel, IPAC, and International
Payment Branch (CAJET). (1) Manages
all activities, policies, quality control,
and audit support for accounts payable
and disbursement functions for travel,
IPAC, and international payments; (2)
serves as the CDC subject matter expert
on all financial matters dealing with all
travel, IPAC, and international
payments; (3) ensures all travel, IPAC,
and international payments are made in
accordance with applicable Federal and
international laws and standards, such
as appropriations law; (4) serves as
liaison with the Department of Treasury,
the CIOs, as well as outside customers,
to provide financial information and
reconcile travel, IPAC, and international
payment issues; (5) compiles and
submits a variety of cash management
and travel reports required by the
Department of Treasury and various
other outside agencies; (6) provides
training and advice on payment, travel
and disbursement issues; (7) manages
transactions related to accounts payable,
such as processing cables,
reimbursements, IPAC disbursements,
and payments for Foreign nationals and
visiting fellows; (8) completes all
reconciliations of sub-legers to general
ledger related to travel, IPAC, and
international payments; (9) responds to
traveler inquiries for vouchers and
certifies payments; (10) manages change
of station payment processing; (11)
perform quality control and quality
assurance reviews; (12) provides
expertise, guidance, oversight, and
interpretation of policies, laws, rules
and regulations for all aspects of travel
procedures and policies at CDC,
including the use of the automated
travel system, local travel, domestic and
foreign temporary duty travel, and
change of station travel for civil service
employees, foreign service employees,
commissioned officers, CDC fellows,
etc.; (13) communicates and implements
departmental travel policies; (14)
manages the administrative aspects of
travel for the agency, including
enforcement of travel card policy,
delegation of authority, distribution of
cash purchase memos, and approval of
first-class memos; (15) serves as liaison
with travel provider for travel contract
matters; (16) provides the CDC’s
E:\FR\FM\05JAN1.SGM
05JAN1
Federal Register / Vol. 77, No. 3 / Thursday, January 5, 2012 / Notices
Emergency Operations Center travel
support; and (17) develops CDC
conference travel planning and
reporting for DHHS and Congress.
Dated: December 22, 2011.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–33791 Filed 1–4–12; 8:45 am]
BILLING CODE 4163–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
emcdonald on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–11–
259: Pregnancy in Women with Disabilities.
Date: January 24, 2012.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Priscah Mujuru, RN, MPH,
DRPH, COHNS, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3139, MSC 7770, Bethesda, MD 20892,
(301) 594–6594, mujurup@mail.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group,
Cancer Etiology Study Section.
Date: January 30–31, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Mandarin Oriental, 1330
Maryland Avenue SW., Washington, DC
20024.
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7804, Bethesda, MD 20892, (301) 435–
1779, riverase@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
VerDate Mar<15>2010
14:51 Jan 04, 2012
Jkt 226001
Group, Developmental Therapeutics Study
Section.
Date: January 30–31, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Marriott, 4100
Admiralty Way, Marina del Rey, CA 90292.
Contact Person: Sharon K Gubanich, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 408–
9512, gubanics@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Clinical, Integrative and Molecular
Gastroenterology Study Section.
Date: January 30, 2012.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Mushtaq A Khan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2176,
MSC 7818, Bethesda, MD 20892, (301) 435–
1778, khanm@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Molecular
Genetics B Study Section.
Date: January 30–31, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Westin Los Angeles Airport Hotel,
5400 West Century Boulevard, Los Angeles,
CA 90045.
Contact Person: Richard A Currie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, (301) 435–
1219, currieri@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Program
Project, Proteome Technologies.
Date: January 30, 2012.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Los Angeles Airport
Hotel, 5400 W Century Boulevard, Los
Angeles, CA 90045.
Contact Person: Richard A Currie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1108,
MSC 7890, Bethesda, MD 20892, (301) 435–
1219, currieri@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Chronic
Fatigue Syndromes.
Date: January 31–February 1, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Lynn E Luethke, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
511
Health, 6701 Rockledge Drive, Room 5166,
MSC 7844, Bethesda, MD 20892, (301) 806–
3323, luethkel@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–33834 Filed 1–4–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Special Pilot
Clinical Studies in Nephrology and Urology.
Date: January 12–13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ryan G Morris, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814 Bethesda, MD 20892, (301) 435–
1501, morrisr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group, Bioengineering of
Neuroscience, Vision and Low Vision
Technologies Study Section.
Date: January 31, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\05JAN1.SGM
05JAN1
]]>Agencies
[Federal Register Volume 77, Number 3 (Thursday, January 5, 2012)]
[Notices]
[Pages 509-511]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33791]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 PR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 76 FR 66308-66309, dated October 26, 2011) is
amended to reflect the reorganization of the Financial Management
Office within the Office of the Chief Operating Officer, Centers for
Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete items (1), (2) and (3) of the functional statements for the
Financial Management Office (CAJE), and insert the following: (1)
Provides leadership and coordination in the development and
administration of the Centers for Disease Control and Prevention's
(CDC) financial management policies; (2) provides leadership and advice
on matters of public health policy, budget formulation, budget and
performance integration, and Congressional appropriations for CDC and
the Agency for Toxic Substances and Disease Registry (ATSDR); (3)
collaborates with the CDC Office of the Director (OD) in the
development and implementation of long-range, strategic program and
financial plans;
Delete in its entirety the title and functional statements for the
Travel Management Activity (CAJE12).
Delete in its entirety the title and functional statements for the
Office of Organizational Excellence (CAJE13) and the Office of
Formulation, Evaluation, and Analysis (CAJE14) and insert the
following:
Office of Management Services (CAJE13). (1) Collaborates and
maintains liaison with CDC management officials to monitor and address
priority issues of concern to CDC leadership; (2) manages the Financial
Management Office's (FMO) operational budget processes, including
planning, execution, and monitoring; (3) manages FMO's acquisition
processes; (4) analyzes and provides recommendations on workload
efficiency and resource utilization; (5) provides direction, strategy,
analysis, operational support, and recommendations in matters
concerning organizational performance and management services within
FMO; (6) coordinates the development of, and maintains, strategic
management and performance measurement tools within FMO; (7) monitors
FMO organizational performance and provides recommendations on
performance improvement; (8) provides management, oversight, and
administrative support for FMO service desk operations; (9) provides
direction, strategy, analysis, and operational support in all aspects
of FMO's human resources operations; (10) provides leading practices in
government financial management practices to FMO; (11) develops,
implements, and manages recruiting, hiring, retention, and succession
strategies; (12) coordinates creation and implementation of operating
standards/procedures and processes, and monitors compliance; (13)
develops, implements, and manages professional development strategy and
plan for FMO; (14) develops and implements FMO's communication strategy
and plan; (15) manages the development and communication of financial
management policies; (16) serves as FMO's point of contact on all
matters concerning facilities management and space utilization; and
(17) serves as FMO's coordinator of COOP activities.
Appropriations, Legislation, and Formulation Office (CAJE14). (1)
[[Page 510]]
Provides leadership, consultation, guidance, and advice on matters of
public health and financial policy; (2) leads all CDC/ATSDR
Congressional appropriations activities; (3) develops CDC/ATSDR's
annual financial and public health policy request in accordance with
DHHS, Office of Management and Budget (OMB), and Congressional
requirements, policies, procedures, and regulations; (4) maintains
liaison with the DHHS, OMB, other government organizations, and
Congress on appropriations and financial policy matters; (5) develops
materials for, and participates in, public health policy and financial
reviews and hearings before DHHS, OMB, and Congress; (6) collaborates
with other parts of CDC, and outside stakeholders, in the development
and implementation of agency-wide financial and public health program
plans; and (7) provides guidance and advice on the consolidation of
budget and performance information as part of CDC's annual budget
request.
Delete the functional statements for the Accounting Branch (CAJEB)
and the Commercial Payment Branch (CAJEE) and insert the following:
Accounting Branch (CAJEB). (1) Oversees and provides accounting for
the Agency; (2) manages accounting treatment for CDC on all business
systems implementations and upgrades to current business systems; (3)
manages all financial audit reviews for FMO and conducts risk
assessment on internal controls; (4) prepares SF 133 Report on Budget
Execution for CDC Appropriation and IDDAs, FACTS I and IT Report and
Year-End Closing Statement (2108 Report), and SF 224 or their
equivalent and all other required financial reports as applicable; (5)
prepares, analyzes fluctuations, and coordinates explanation for
differences on all required financial statements and notes: (6)
performs GPRA reporting analysis for compliance; (7) ensures compliance
of Federal and Department reporting requirements; (8) coordinates
accounting policy issues with the Department of Health and Human
Services (DHHS) Office of Financial Policy and FMO's Office of
Management Services; (9) manages Fund Balance with Treasury, including
authority, disbursements (payroll and non-payroll), collections,
deposit funds and budget clearing accounts; (10) prepares manual and
ADI journal vouchers for corrections to the general ledger; (11)
performs monthly, quarterly, and year-end close out process of the
general ledger; (12) serves as liaison with the Procurements and Grants
Office, Buildings and Facilities Offices, Program Offices, and Budget
Execution Services on capital asset procedures; (13) manages financial
accounting for all assets for CDC, including real and personal
property, equipment, land, leases, software, personal property, and
stockpiles; (14) conducts financial and inventory reconciliations for
all applicable assets, including inventory such as Vaccine for Children
and Strategic National Stockpile, real and personal property,
equipment, leases, leasehold improvements, land, and others as needed;
(15) leads and directs grants management activities within FMO; (16)
provides training and assistance to CDC project officers and grants
management officials on various financial management aspects of grants;
(17) serves as liaison with grantees and other operating divisions for
financial questions/inquiries related to grants; (18) manages the
process to perform grant processing for commitments, obligations,
advances, disbursements, and accruals; (19) manages grants
transactions, such as vendor set-up, establishing sub-accounts, Common
Accounting Number set-up within the Payment Management System (PMS),
reconciling sync file to PMS, and posting files from PMS; (20) conducts
grant reviews, monitors rates of expenditure for existing grant awards,
and supports Program in grant execution; and (21) records undelivered
order adjustments or obligations as needed.
Commercial Payment Branch (CAJEE). (1) Manages all activities,
policies, quality control, and audit support for accounts payable and
disbursement functions for commercial payments; (2) serves as the CDC
subject matter expert on all financial matters dealing with commercial
payments; (3) ensures all commercial payments are made in accordance
with applicable Federal laws and standards, such as Appropriations Law;
(4) serves as liaison with the Department of Treasury, the Centers/
Institutes/Offices (CIO's), as well as outside customers, to provide
financial information and reconcile commercial payment issues; (5)
provides training and advice on commercial payment and disbursement
issues; (6) manages transactions related to commercial accounts payable
and disbursements; (7) completes all reconciliations of sub-legers to
general ledger related to commercial payments; (8) compiles and submits
a variety of cash management and commercial reports required by
Treasury and various outside agencies; (9) responds to commercial
inquiries for invoices and certifies payments; (10) performs Quality
Control and Quality Assurance reviews and participates in internal
reviews; and (11) assists with undelivered order adjustments or
obligations as needed.
Delete in its entirety the title and function statements for the
Grants and Asset Management Branch (CAJEK).
After the functional statements for the Budget Execution Branch 6
(CAJES) insert the following:
Travel, IPAC, and International Payment Branch (CAJET). (1) Manages
all activities, policies, quality control, and audit support for
accounts payable and disbursement functions for travel, IPAC, and
international payments; (2) serves as the CDC subject matter expert on
all financial matters dealing with all travel, IPAC, and international
payments; (3) ensures all travel, IPAC, and international payments are
made in accordance with applicable Federal and international laws and
standards, such as appropriations law; (4) serves as liaison with the
Department of Treasury, the CIOs, as well as outside customers, to
provide financial information and reconcile travel, IPAC, and
international payment issues; (5) compiles and submits a variety of
cash management and travel reports required by the Department of
Treasury and various other outside agencies; (6) provides training and
advice on payment, travel and disbursement issues; (7) manages
transactions related to accounts payable, such as processing cables,
reimbursements, IPAC disbursements, and payments for Foreign nationals
and visiting fellows; (8) completes all reconciliations of sub-legers
to general ledger related to travel, IPAC, and international payments;
(9) responds to traveler inquiries for vouchers and certifies payments;
(10) manages change of station payment processing; (11) perform quality
control and quality assurance reviews; (12) provides expertise,
guidance, oversight, and interpretation of policies, laws, rules and
regulations for all aspects of travel procedures and policies at CDC,
including the use of the automated travel system, local travel,
domestic and foreign temporary duty travel, and change of station
travel for civil service employees, foreign service employees,
commissioned officers, CDC fellows, etc.; (13) communicates and
implements departmental travel policies; (14) manages the
administrative aspects of travel for the agency, including enforcement
of travel card policy, delegation of authority, distribution of cash
purchase memos, and approval of first-class memos; (15) serves as
liaison with travel provider for travel contract matters; (16) provides
the CDC's
[[Page 511]]
Emergency Operations Center travel support; and (17) develops CDC
conference travel planning and reporting for DHHS and Congress.
Dated: December 22, 2011.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-33791 Filed 1-4-12; 8:45 am]
BILLING CODE 4163-18-M
